Lb Pharmaceuticals (LBRX) Leases (2024 - 2026)

Lb Pharmaceuticals has reported Leases for 3 years, with the latest figure at $2.1 million in Q1 2026.

• For the quarter ending Q1 2026, Leases changed N/A year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at $2.1 million (changed N/A YoY), and the FY2025 full-year result was $2.2 million, down 6.4% from the prior year.
• Leases for Q1 2026 stood at $2.1 million, down from $2.2 million in the prior quarter.
• The five-year high for Leases was $2.3 million in Q4 2024, with the low at $2.1 million in Q1 2026.
• Average Leases over 3 years is $2.2 million, with a median of $2.2 million recorded in 2025.
• Peak annual rise in Leases reached 6.4% in 2025, while the deepest fall reached 6.4% in 2025.
• Tracing LBRX's Leases over 3 years: stood at $2.3 million in 2024, then dropped by 6.4% to $2.2 million in 2025, then decreased by 2.32% to $2.1 million in 2026.
• The last three Leases figures came in at $2.1 million (Q1 2026), $2.2 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.

Peer Comparison